Curis Reports Third Quarter 2020 Financial Results

Go back to Curis Reports Third Quarter 2020 Financial Results

Curis (CRIS) Tops Q3 EPS by 2c

November 10, 2020 4:23 PM EST

Curis (NASDAQ: CRIS) reported Q3 EPS of ($0.11), $0.02 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $2.57 million.

"We have continued to advance our clinical programs towards important catalysts at the end of this year and into 2021, which we expect to be another important year of data for Curis," said James Dentzer, President and Chief... More